June 21, 2024
Cardiac Valvulotome Market

Cardiac Valvulotome Market is Estimated to Witness High Growth Owing to Growing geriatric population with heart valve disorders.

Cardiac valvulotome are medical instruments used for dissecting or cutting cardiac valves during valve replacement surgeries. It helps clear up the diseased or damaged native heart valves to prepare the annulus for implantation of prosthetic heart valves. Some key advantages of cardiac valvulotome include precise cutting, controlled tissue removal, and minimal trauma to surrounding tissues. The growing prevalence of heart valve disorders such as stenosis and regurgitation among geriatric population has significantly driven the demand for cardiac valvulotome procedures in recent years.

The Global cardiac valvulotome market is estimated to be valued at US$ 157.2 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Cardiac Valvulotome Market Size are LeMaitre, INVAMED, GeoSurgical, LimFlow, Inc., B. Braun SE, Teleflex Incorporated, StarFish Product Engineering Inc., Koven Technology Canada Inc., Andramed, Zgrum Medical, BD, PEAK SURGICAL, and Symmetry Surgical Inc. These key players collectively accounted for nearly 65-70% of the global cardiac valvulotome market share in 2023.

The cardiac valvulotome market offers lucrative growth opportunities owing to rising demand for minimally invasive heart valve replacement surgeries. Moreover, technological advancements focused on developing miniature, single-use, and eco-friendly valvulotome instruments will further drive the market growth.

Geographically, North America dominated the global cardiac valvulotome market and was valued over US$ 50 Mn in 2023. However, Asia Pacific region is expected to witness fastest growth during the forecast period supported by growing medical tourism industry and increasing healthcare expenditure in emerging countries such as China and India.

Market drivers

The rising geriatric population worldwide prone to age-related heart valve disorders is a major market driver. It is estimated that by 2050, over 16% of the world’s population will be aged 65 years and above. This growing pool of elderly population will accentuate the demand for cardiac valvulotome procedures in the coming years. Secondly, increasing investments by key players to develop advanced valvulotome technologies will contribute to the market growth. Lastly, favorable health reimbursement policies for heart valve replacement surgeries in developed nations will continue to drive the cardiac valvulotome market during the forecast period.

PEST Analysis

Political: Government regulations and approvals play a major role in the cardiac valvulotome market. Increasing focus on patient safety and efficacy is driving stricter regulations.

Economic: Rising healthcare spending along with growing incidence of cardiac diseases is fueling demand for cardiac valvulotomes. However, high cost of treatments impacts the market.

Social: Growing awareness about heart health and innovative surgical procedures for treating valvular heart diseases is positively influencing the market. However, social stigma sometimes prevents people from opting for treatments.

Technological: Advancements in minimally invasive cardiac surgeries including valve replacement are propelling the market. Increased adoption of robot-assisted surgeries is expected to open new growth avenues in the forecast period.

The cardiac valvulotome market in terms of value is concentrated mainly in North America and Europe. This can be attributed to robust healthcare infrastructure, advanced surgical facilities, and presence of major market players in these regions.

The Asia Pacific region is poised to emerge as the fastest growing market for cardiac valvulotomes over the forecast period. Factors such as growing cardiac patient pool, rising healthcare expenditure, increasing focus on research and development are fueling market growth in Asia Pacific countries. Rapidly developing economies and improving access to healthcare are supporting the cardiac valvulotome market expansion in this region.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it